•  
  •  
 

Abstract

Obesity, a prevalent metabolic disorder characterized by excessive fat accumulation, can severely affect overall health if left untreated. This study investigated the potential of a 70% ethanol extract from Piper crocatum (red betel) leaves as an in vitro inhibitor of pancreatic lipase (PL), supported by computational analyses to identify alternative compounds to orlistat. The phytochemical profile was characterized using LC-MS/MS, revealing alkaloids and terpenoids with contents of 1.1 ± 0.01 mg CE/g and 3.14 ± 0.3 mg UAE/g, respectively. The extract exhibited 49 ± 9.1% inhibition of PL activity. Molecular docking identified three promising compounds: calanolide A (10.43 kcal/mol), myricanone (10.04 kcal/mol), and (-)-8-prenylnaringenin (9.49 kcal/mol). Based on DFT studies, these compounds showed favorable ADMET and electronic properties. MD simulations demonstrated that the PL-calanolide A complex maintained high conformational stability over 100 ns with a binding energy of 150.75 kJ/mol (MM-PBSA). These findings suggest that red betel leaf extract may serve as a promising natural pancreatic lipase inhibitor, as supported by robust in vitro and computational evidence supporting its potential for future anti-obesity drug development.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS